ProPhase Labs (NASDAQ:PRPH) Now Covered by StockNews.com

Equities research analysts at StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH) in a research note issued on Tuesday. The firm set a “sell” rating on the stock.

ProPhase Labs Price Performance

NASDAQ PRPH opened at $0.53 on Tuesday. ProPhase Labs has a 1 year low of $0.22 and a 1 year high of $7.48. The company has a fifty day simple moving average of $0.53 and a 200 day simple moving average of $1.44. The company has a current ratio of 1.47, a quick ratio of 1.33 and a debt-to-equity ratio of 0.48. The company has a market cap of $12.75 million, a P/E ratio of -0.42 and a beta of -0.37.

Institutional Investors Weigh In On ProPhase Labs

Several hedge funds and other institutional investors have recently made changes to their positions in the business. SVB Wealth LLC acquired a new position in shares of ProPhase Labs during the 4th quarter worth about $36,000. Squarepoint Ops LLC bought a new position in ProPhase Labs in the 4th quarter worth approximately $40,000. Warberg Asset Management LLC bought a new position in ProPhase Labs in the 4th quarter worth approximately $77,000. Perritt Capital Management Inc lifted its holdings in shares of ProPhase Labs by 129.1% during the fourth quarter. Perritt Capital Management Inc now owns 190,000 shares of the company’s stock worth $144,000 after buying an additional 107,068 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of ProPhase Labs by 26.6% in the fourth quarter. Geode Capital Management LLC now owns 203,528 shares of the company’s stock valued at $154,000 after acquiring an additional 42,793 shares during the period. 9.45% of the stock is owned by institutional investors and hedge funds.

About ProPhase Labs

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.